Prevention of infections including vaccination strategies in multiple myeloma

Heinz Ludwig, Shaji Kumar

Research output: Contribution to journalReview articlepeer-review


Infections are a major cause of morbidity and mortality in multiple myeloma. The increased risk for bacterial and viral infections results mainly from the disease-inherent and treatment-induced immunosuppression. Additional risk factors are older age with immune senescence, T cell depletion, polymorbidity, and male gender. Hence, every effort should be taken to reduce the risk for infections by identifying patients at higher risk for these complications and by implementing prophylactic measures, including chemoprophylaxis and immunization against various relevant pathogens. Here, we review the available evidence and provide recommendations for medical prophylaxis and vaccination in clinical practice.

Original languageEnglish (US)
Pages (from-to)S46-S62
JournalAmerican journal of hematology
Issue numberS2
StatePublished - Mar 2023

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Prevention of infections including vaccination strategies in multiple myeloma'. Together they form a unique fingerprint.

Cite this